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Electrophysiological identification of glucose-sensing
neurons in rat nodose ganglia
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The vagal afferent system is strategically positioned to mediate rapid changes in motility
and satiety in response to systemic glucose levels. In the present study we aimed to
identify glucose-excited and glucose-inhibited neurons in nodose ganglia and characterize
their glucose-sensing properties. Whole-cell patch-clamp recordings in vagal afferent neurons
isolated from rat nodose ganglia demonstrated that 31/118 (26%) neurons were depolarized
after increasing extracellular glucose from 5 to 15 mm; 19/118 (16%) were hyperpolarized, and
68/118 were non-responsive. A higher incidence of excitatory response to glucose occurred in
gastric- than in portal vein-projecting neurons, the latter having a higher incidence of inhibitory
response. In glucose-excited neurons, elevated glucose evoked membrane depolarization
(11 mV) and an increase in membrane input resistance (361 to 437 M). Current reversed at
−99 mV. In glucose-inhibited neurons, membrane hyperpolarization (−13 mV) was associated
with decreased membrane input resistance (383 to 293 M). Current reversed at −97 mV.
Superfusion of tolbutamide, a KATP channel sulfonylurea receptor blocker, elicited identical
glucose-excitatory but not glucose-inhibitory responses. Kir6.2 shRNA transfection abolished
glucose-excited but not glucose-inhibited responses. Phosphatidylinositol bisphosphate (PIP2)
depletion using wortmannin increased the fraction of glucose-excited neurons from 26% to
80%. These results show that rat nodose ganglia have glucose-excited and glucose-inhibited
neurons, differentially distributed among gastric- and portal vein-projecting nodose neurons. In
glucose-excited neurons, glucose metabolism leads to KATP channel closure, triggering membrane
depolarization, whereas in glucose-inhibited neurons, the inhibitory effect of elevated glucose
is mediated by an ATP-independent K+ channel. The results also show that PIP2 can determine
the excitability of glucose-excited neurons.
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Introduction
Although the presence of glucose-sensing neurons in
the hypothalamus was first reported more than 50 years
ago (Mayer, 1953), little is known about the site and
mechanism by which alterations in blood glucose level are
sensed. In general, glucose-sensing neurons in the brain
are involved in the control of neuroendocrine function,
nutrient metabolism and energy homeostasis (Levin et al.
2004). The glucose-sensing neurons in the brain are
unlikely to play a major role in mediating digestive
function in response to changes in circulating glucose
levels because changes in cerebrospinal fluid glucose level
ranges between only 10 and 30% of blood glucose levels,
and therefore may not be rapid or sensitive enough to
reflect changes in peripheral glucose levels (Levin et al.
2004).
Research suggests that acute hyperglycaemia affects
a subpopulation of neurons in the nucleus tractus
solitarii (NTS) and dorsal motor nucleus of the vagus
(DMV) (Mizuno & Oomura, 1984; Kobashi & Adachi,
1994; Ferreira et al. 2001; Balfour et al. 2006). Several
investigators have shown that glucose injection into the
DMV of anaesthetized rats decreases gastric motility
(Sakaguchi et al. 1985). Ferreira et al. (2001) demonstrated
that glucose administration into the NTS modulates
gastric motor function. However, these studies failed to
show that NTS and DMV neurons are true primary sensors
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of peripheral glucose, thus rendering the physiological
relevance of these observations unclear.
Recent studies in our laboratory showed that acute
hyperglycaemia in rats reduces gastric contractions in a
dose-dependent manner, an action abolished by perivagal
capsaicin application or vagal rootlet sectioning (Zhou
et al. 2008). Further, we showed that hyperglycaemia
stimulates vagal afferent pathways, which in turn activate
vagal efferent cholinergic pathways synapsing with intra-
gastric nitric oxide-containing neurons to mediate gastric
relaxation (Zhou et al. 2008). Hence, vagal afferent
pathways are likely to play an important role in glucose
sensing.
The vagovagal pathways appear to be involved in
the detection of hypoglycaemia and the regulation of
eating behaviour. Traditionally attributed to the CNS,
glucose sensors in the portohepatic region are now
recognized to play an important role in modulating the
response to glycaemia (Hevener et al. 1997). Novin et al.
(1973) showed that vagotomy abolished the increased
eating observed in rabbits after 2-deoxyglucose (2-DG)
infusion into the portal vein, but had no effect on the
eating behaviour of rabbits receiving 2-DG infusion into
the jugular vein. Del Prete & Scharrer (1990) further
demonstrated that the eating response to 2-DG in rats
was reduced by hepatic branch vagotomy. We have
confirmed and extended these findings, showing that
glucose sensing in the portal vein is mediated by vagal
afferents (Grabauskas et al. 2008a). These observations are
consistent with the idea that portohepatic glucose sensors
play a critical role in the detection of the transient pre-meal
decline in blood glucose and the reliable translation of this
decline into meal initiation. In contrast to the liver, which
has little or no vagal afferent innervation, the portal vein is
richly innervated by afferent fibres sensitive to changes in
metabolite concentration, pressure and osmolarity (Lautt,
1983; Shimazu, 1987). In vivo motility (Zhou et al. 2008)
and eating behaviour studies in rodents (Novin et al. 1973;
Del Prete and Scharrer 1990; Grabauskas et al. 2008a)
suggest that sensing of circulatory glucose levels occurs in
the nodose ganglia. Hence, in this study we determined
the presence of glucose-excited and glucose-inhibited
neurons in the nodose ganglia. Patch-clamp recording,
immunocytochemistry, and signal transduction studies
using pharmacological tools and small inhibitory RNA
(siRNA) technologies facilitated further examination of




All procedures were performed in accordance with
National Institutes of Health guidelines and with the
approval of the University Committee on Use and Care
of Animals at the University of Michigan. We have read
the article ‘Reporting ethical matters in The Journal of
Physiology: standards and advice’ and our experiments
comply with the policies and regulations (Drummond,
2009).
Retrograde tracing of nodose ganglia
Thirty-one Sprague–Dawley rats (2–4 weeks of age)
of either sex were deeply anaesthetized with a 4%
mixture of halothane in air as described previously
(Grabauskas & Moises, 2003). Following laparotomy,
crystals of the retrograde tracer 1,1′-dioctadecyl-3,3,
3′3-tetramethylindocarbocyanine (DiI; Molecular
Probes/Invitrogen, Carlsbad, CA, USA) were applied to
either the gastric corpus or the portal vein. To confine
the dye to the site of application, crystals of DiI were
embedded in a fast hardening epoxy resin that was
allowed to harden for approximately 5 min. This was
followed by washing of the surgical area with warm sterile
saline and the wound was closed with nylon sutures
(4–0). The animal was allowed to recover for 10–15 days
prior to being killed for nodose ganglia dissection. In 20
experiments DiI was applied to the corpus and in 11 to
the portal vein.
Isolation and culture of nodose ganglia neurons
Forty-eight male Sprague–Dawley rats were anaesthetized
with ketamine at 250 mg kg−1 and xylazine at 25 mg kg−1
(Peter et al. 2006). The depth of anaesthesia was monitored
by testing a paw withdrawal reflex. Following the
dissection of the nodose ganglia the animal was killed
by injecting an overdose of urethane (3–5 g kg−1) and
severing the aorta. The ganglia were placed in a 35 mm
culture dish containing Ca2+- and Mg2+-free Hanks’
balanced salt solution with penicillin and streptomycin.
Desheathed ganglia were sliced into small fragments and
placed in a 1.5 ml centrifuge tube containing digestion
buffer (dispase II and collagenase IA, 1 mg ml−1). After
incubation at 37◦C for 60 min, cells were dispersed
by gentle trituration through Pasteur pipettes and
washed in Dulbecco’s modified Eagle’s medium (DMEM).
The cells were resuspended in L15 medium (GIBCO
BRL/Invitrogen) containing 10% fetal bovine serum,
plated onto poly-L-lysine-coated (100 μg ml−1) coverslips
for 30 min, and cultured in DMEM with 10% fetal
calf serum at 37◦C. Neurons were stuck to coverslips
and maintained in culture for 24–48 h at 37◦C prior to
recording.
Patch-clamp electrophysiology
Prior to electrophysiological recording, retrogradely
labelled nodose ganglia neurons were identified using
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a Nikon E600 FN microscope equipped with TRITC
epifluorescence filters. Unless otherwise indicated,
recordings were made in neurons that were unequivocally
identified as labelled with DiI. All measurements were
made in a physiological saline solution composed of (in
mM): 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 5 glucose,
10 mannitol and 10 Hepes; pH adjusted to 7.3 with
NaOH. Mannitol was used to adjust the osmolarity of
the test solution depending on the concentration of
glucose used (5 or 10 mM). Whole-cell or perforated
patch recordings were performed using borosilicate glass
electrodes with resistance between 3 and 6 M (A-M
Systems, Carlsborg, WA, USA) backfilled with a saline
solution composed of (in mM): 130 potassium gluconate,
10 Hepes, 10 EGTA, 1.0 MgCl2, 2.5 CaCl2, 1.0 ATP and
0.3 GTP. For the perforated patch recording, the internal
solution also included 0.5 mg ml−1 amphotericin B
(Sigma-Aldrich). Current and voltage recordings were
obtained from discrete isolated nodose ganglia neurons
using the Axopatch 200B patch-clamp amplifier (Axon
Instruments, Sunnyvale, CA, USA) filtered at 2 kHz using
a four-pole low-pass Bessel filter. For data analysis,
signals were digitized using an analog-to-digital converter
Digidata 1322B (Axon Instruments/Molecular Devices),
and stored and analysed on a personal computer running
pCLAMP 9 software (Axon Instruments/Molecular
Devices).
Western blotting
Nodose ganglia were obtained from three rats and
pooled for Western blot analyses. The neurons were lysed
and centrifuged at 14 000 g for 10 min. Protein samples
were then run on Ready Gel 12% Tris-HCl (Bio-Rad,
Hercules, CA, USA) for 1.5 h at 80 V. Proteins were
then transferred to polyvinylidene difluoride membranes
for 1 h at 80 V. The membranes were blocked with
StartBlock buffer T20 (Thermo Fisher Scientific, Waltham,
MA, USA) for 1 h at room temperature, probed
with primary antibodies against Kir6.2 (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) at 1 : 600 dilution or
antibodies against sulfonylurea receptor 1 (SUR1) (Santa
Cruz Biotechnology) at 1 : 500 dilution at 4◦C overnight,
and then washed in Tris-buffered saline for 1 h. The
membranes were probed with corresponding horseradish
peroxidase-conjugated secondary antibodies at 1 : 2000
dilution. The resulting bands were scanned with an Epson
2400 and analysed using ImageJ.
Immunocytochemistry
Immunocytochemistry studies to localize the inwardly
rectifying K+ channel (Kir6.2) and the sulfonylurea
receptor 1 (SUR1) were performed on nodose ganglia
neurons. Following anaesthesia with urethane, a trans-
cardial perfusion was performed with ice-cold heparinized
phosphate-buffered saline (PBS) and subsequently with
fixative containing 4% paraformaldehyde, 0.2% picric
acid and 0.35% glutaraldehyde in phosphate buffer
(0.1 mol l−1, pH 7.4). The left and right nodose ganglia
were removed and placed in the same fixative for
2 h at room temperature and then in 25% sucrose in
PBS (0.1 mol l−1) overnight at 4◦C. The ganglia were
cut in longitudinal sections measuring 5 μM using a
precision cryostat (Leica Microsystems, Bannockburn, IL,
USA). The sections were collected in serially ordered
sets, thaw-mounted on gelatin–chromium coated slides,
and stored at −70◦C. For permeabilization and back-
ground reduction, sections of the nodose ganglia were
incubated in 5% normal donkey serum in PBS for 1 h
at room temperature. Single or double labelling was
performed using the primary antibodies against Kir6.2
(H-55, 1 : 250) and SUR1 (H-80, 1 : 250). The primary
antibodies were diluted in PBS containing 2% normal
donkey serum, 0.3% Triton X-100 and 0.1% sodium azide,
and tissues were incubated overnight at room temperature.
The tissues were washed in PBS and then exposed
for 1 h to species-specific Alexa Fluor 488 (Molecular
Probes/Invitrogen,) or cyanine 3-conjugated secondary
antibodies (Jackson ImmunoResearch Laboratories, West
Grove, PA, USA) diluted in PBS containing 0.3% Triton
X-100. The sections were coverslipped and then sealed.
The specificity of antibodies was demonstrated by leaving
out the primary antibodies or secondary antibodies
during the staining procedure, which resulted in complete
abolition of staining of the nodose ganglia.
All preparations were examined with an epifluorescence
microscope or a Zeiss LSM 510 laser scanning confocal
microscope. The images were analysed by using
filter combinations that enabled separate visualization
of multiple fluorophores. The images from the
epifluorescence microscope were taken with a Zeiss
AxioCam digital camera. Images were stored and analysed
with Image-Pro Plus software (Media Cybernetics,
Bethesda, MD, USA) or Adobe Photoshop CS2. The digital
images taken by the confocal microscope were analysed by
Zeiss LSM Image Browser and Adobe Photoshop CS2.
Transfection of nodose ganglia with Kir6.2 short
hairpin RNA
Construction of pLentilox 3.7 TRESK shRNA. Kir6.2
short hairpin RNA (shRNA) sequences were
designed with the Kir6.2 nucleotides (NM–031358)
flanked with blunt T/A bp on the 5′ end and
an XhoI sticky end on the 3′ end (sense strand:
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DNA Technologies, Coralville, IA, USA). Both sense
and antisense strands were generated by oligonucleotide
synthesis with 5′-phosphate and polyacrylamide gel
electrophoroesis (PAGE) purification. To introduce
RNAi stem-loop, complementary strands of the Kir6.2
sequences were annealed and inserted into the HpaI and
XhoI sites of a shRNA-expressing vector pLL3.7, which
was contained the mouse U6 promoter upstream of
CMV-EGFP expression cassette (Rubinson et al. 2003).
Generation of the lentiviral vector. pLL3.7–Kir6.2
shRNA plasmids and packaging plasmid (pMLDg/pRRE,
pRSV-Rev, pCI-VSVG) were transfected into 293T cells
by standard calcium phosphate precipitation methods.
The supernatant was collected after 72 h and pelleted
by centrifugation at 12 300g in a Beckman JA-17 rotor
(Beckman Coulter, Fullerton, CA, USA). The viral pellet
was then resuspended in DMEM at 10X the original
concentration. The resulting shRNA lentiviruses were
quality tested in A549 cells. The lenti-Kir6.2 shRNA
was shown to transduce greater than 60% of A549
cells, as determined by fluorescence-activated cell sorter
(FACS) analysis, which measured the enhanced green
fluorescent protein (EGFP) marker in the recombinant
lentiviral genome. Scrambled siRNA (siRNA-A; Santa
Cruz Biotechnology) was used as control siRNA.
Figure 1. Continuous membrane potential recordings depict
typical responses of glucose-insensitive (A), glucose-excited (B)
and glucose-inhibited (C) nodose ganglia neurons to an
increase in extracellular glucose (5 to 15 mM)
Cell infection. Primary nodose ganglia neuronal cultures
were supplemented with (20–100) × 106 TU of
lenti-Kir6.2 shRNA or scrambled siRNA viral particles
at 37◦C. After 3 h, media containing lentiviral particles
were aspirated and replaced with DMEM/F-12 media
containing 100 mg dl−1 of glucose and 10% fetal calf
serum supplemented with gentamycine (100 U ml−1). The
neurons were cultured for 72–96 h at 37◦C in a 5% CO2
atmosphere.
Statistical analyses
All values are expressed as means ± S.E.M. Significance
levels were set at P < 0.05 and were calculated using
two-way ANOVA or Fisher’s exact test. All statistical
analyses were performed using InStat software (GraphPad
Software, Inc, La Jolla, CA, USA).
Results
Demonstration of glucose-excited and
glucose-inhibited neurons in the nodose ganglia
We conducted whole-cell patch-clamp recordings of
isolated nodose neurons. Some recordings were performed
on retrogradely labelled afferent neurons whose
projections to the gastrointestinal tract had been
established using the retrograde fluorescent tracer DiI.
Whole-cell recordings were obtained from 118 nodose
neurons, including 51 innervating the gastric corpus and
35 projecting to the portal vein. Thirty of 118 neurons
were spontaneously active. Resting membrane potentials
were between −52 and −65 mV (mean −59 ± 3 mV).
Overshooting action potential amplitudes ranged from
70 to 123 mV (mean 93 ± 4.1 mV). In response to a
500 ms −100 pA hyperpolarizing current pulse, input
resistance ranged between 205 and 490 M (mean
360 ± 23 M). Under these conditions, 31/118 (26%)
neurons examined were glucose excited; the neuronal
membrane potential was depolarized on increasing
the extracellular glucose concentration from 5 to
15 mM (Figs 1 and 2). Nineteen of 118 (16%) neurons
were glucose inhibited, exhibiting hyperpolarization
in response to the elevated glucose concentration;
68 neurons (58%) did not respond to the glucose
concentration transition. Interestingly, the proportion of
glucose-excited and glucose-inhibited neurons differed
significantly among the gastric- and portal vein-projecting
neurons. Gastric-projecting neurons had a significantly
higher incidence of glucose-excitatory response (19/51,
37%) when compared with portal vein-projecting
neurons (4/36, 11%) (P < 0.05). Conversely, portal
vein-projecting neurons had a significantly higher
incidence of glucose-inhibitory response (10/36, 28%)
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when compared with gastric-projecting neurons (4/51,
8%) (P < 0.05).
In general, many of the glucose-excited neurons were
quiescent under basal conditions, whereas the majority
of glucose-inhibited neurons were spontaneously active
(Fig. 1). However, this baseline characteristic is by no
means uniform. Both types of basal activities were
observed in both glucose-excited and glucose-inhibited
Figure 2. Effects of glucose on the membrane properties of nodose ganglia neurons
A, continues membrane potential recording shows that increase in extracellular glucose concentration from 5
to 15 mM (bar) depolarized the membrane potential sufficient to elicit action potentials. The depolarization was
associated with the increase in neuronal input resistance; the neuronal input resistance was tested every 40 s by
injecting 500 ms, 100 pA amplitude current pulses (negative membrane potential deflections). To evaluate changes
in the membrane input resistance the membrane potential was current clamped back (box). Note that after glucose
concentration was restored to 5 mM, membrane potential and input resistance returned to baseline within 30 min.
B, the same experiment illustrated in A is depicted on an expanded time scale illustrating the membrane potential
response to injection of 100 pA current pulse at 5 mM (left) and 15 mM (right) glucose concentration (potential
was current clamped back). C, continues membrane potential recording shows that increase in extracellular
glucose concentration from 5 mM to 15 mM hyperpolarized the membrane potential in a glucose inhibited neuron.
The hyperpolarization was associated with a decrease in neuronal input resistance. To evaluate changes in the
membrane input resistance the membrane potential was current clamped back (box). Note that the effect of
hyperpolarization was sustained after 30 min of recording. D, the same experiment illustrated in C is depicted on
an expanded time scale to show the membrane potential response to injection of 100 pA current pulse at 5 mM
(left) and 15 mM (right) glucose concentration (potential was current clamped back).
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neurons. The general characteristics of glucose-excited
neurons are shown in Fig. 3A and B. In response to
an increase of the extracellular glucose concentration,
glucose-excited neurons showed an increased membrane
input resistance from 361 ± 22 to 437 ± 27 M (n = 31,
P < 0.05) and this was associated with membrane
potential depolarization of 11 ± 3 mV lasting 30–60 min.
The I–V relationship showed that the current reversed at
−99 ± 6 mV (n = 31), which is close to the theoretical
K+ equilibrium potential of −105 mV in the solution
used, suggesting that glucose-evoked excitation was due
to closure of K+ channels. In glucose-inhibited neurons,
the higher glucose concentration decreased the membrane
input resistance from 383 ± 26 to 293 ± 16 M (n = 19,
P < 0.05) and this was associated with membrane
potential hyperpolarization of 13 ± 4 mV (Fig. 3C and
D). The hpyperpolarization persisted throughout the
time of recording, ∼1 h. The current reversal potential
was −98 ± 4 mV (n = 19), which is also similar to the
K+ equilibrium potential of −105 mV. The electro-
physiological properties of the nodose ganglia neurons
in response to transition of glucose concentrations from
5 to 15 mM did not change after 72–96 h in tissue culture
(n = 20) (data not shown).
Protein expression of Kir6.2 in the rat nodose ganglia
The KATP channel is formed from Kir6.2 channel-forming
units and the regulatory sulfonylurea receptor (SUR)
(Enkvetchakul & Nichols, 2006). Kir6.2 protein and
SUR1 protein were abundant in rat nodose ganglia
as demonstrated by Western blot analyses (Fig. 4A).
Immunocytochemistry revealed intense staining of Kir6.2
in almost all nodose ganglia neurons (Fig. 4B). This same
group of neurons also displayed intense immunostaining
of SUR1 (Fig. 4C), confirming that the full KATP channel is
present in almost all the neurons in the rat nodose ganglia.
Electrophysiological evidence that glucose-evoked
current is mediated by the KATP channel
Our data suggest that K+ ions mediate the effects of
glucose in nodose ganglia neurons. KATP channels have
been implicated as the underlying mechanism responsible
for the glucose-sensing mechanism in pancreatic β-cells
and ventromedial hypothalamic neurons (Levin et al.
2004). Opening of the KATP channel produces a K+
current that hyperpolarizes the cell and reduces electrical
excitability. Conversely, KATP channel closure increases
membrane excitability (Song & Ashcroft, 2001). We
used pharmacological activation and inhibition of KATP
channels to determine the presence of these channels in
nodose ganglia neurons. Tolbutamide and diazoxide were
used as a KATP channel inhibitor and opener, respectively.
Bath application of tolbutamide (200 μM) depolarized
recorded neurons (Fig. 5A). I–V relationships revealed
that tolbutamide application inhibited the membrane
current with a reversal potential of −92 ± 4 mV in
6/20 neurons recorded (Fig. 5B). In contrast, bath
application of diazoxide (200 μM) activated a membrane
current with a reversal potential of −93 ± 5 mV (n = 5,
Fig. 5D). In addition, no further increase in neuro-
nal excitability in response to a glucose concentration
transition from 5 to 15 mM was observed following
tolbutamide (200 μM) treatment. (n = 6; data not shown).
In glucose inhibited neurons, tolbutamide (200 μM) did
not attenuate the hyperpolarization current generated by
‘high’ glucose concentration (15 mM) (Fig. 5C), indicating
that KATP channels do not modulate the excitability of
glucose inhibited neurons. These electrophysiological data
support the notion that the KATP channel plays a role in
the mediation of glucose-excitatory responses.
Kir6.2 subunit silencing with a lentiviral vector
Viral vectors are efficient gene delivery tools in mammalian
cells (Rubinson et al. 2003). We developed a lentiviral
vector that expresses RNA, including Kir6.2 subunit
shRNAs. This vector was engendered to co-express
EGFP as a reporter gene, permitting identification of
infected cells. Our Western blot data demonstrated a 55%
reduction in Kir6.2 protein expression in primary neuro-
nal cultures of nodose ganglia neurons infected with the
lentiviral vector (Fig. 6A) (n = 3). About 65–75% of the
cultured neurons were EGFP positive and showed weak
or no immunoprecipitation for anti-Kir6.2 (Fig. 6B and
C). On the other hand, nodose ganglia neurons that
were transfected with scrambled siRNA were positive for
both EGFP and anti-Kir6.2 (Fig. 6D and E). Thus, the
lentiviral vector is capable of stably expressing transgenes
that silence Kir6.2 mRNA in nodose ganglia neurons.
To demonstrate the role of the KATP channel in the
mediation of glucose-evoked depolarization, we used
primary nodose ganglia cultures transfected with the
scrambled siRNA or lentiviral vector that targeted Kir6.2
mRNA expression. After incubation for 72–96 h, we
examined nodose ganglia neuronal responsiveness to
extracellular glucose concentration transition. Only
lentiviral vector transfected EGFP-positive cells were used
for electrophysiogical recordings. None of the recorded
transfected neurons with siRNA for Kir6.2 responded to
the glucose concentration transition from 5 to 15 mM
(n = 20) or the extracellular application of tolbutamide
(n = 5, data not shown). However, 2/20 (10%) of the trans-
fected neurons recorded were inhibited by the increase
in extracellular glucose concentration. On the other
hand, 3 and 1 of 10 recorded neurons transfected with
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Figure 3. Glucose levels modulate the membrane properties of nodose ganglia neurons
A, current–clamp responses show that increase in extracellular glucose (Glu) increased the excitability of
glucose-excited neurons, and this was associated with an increase in membrane input resistance; note the increase
in amplitude of the negative membrane potential deflection evoked by negative current pulses. B, current–voltage
(I–V ) relationships from a glucose-excited neuron show that an increase in extracellular glucose concentration
increased the slope of the relationship; the effect reversed at −108 mV, close to the estimated K+ equilibrium
potential. C, current-clamp responses demonstrate that an increase in extracellular glucose hyperpolarized the
recorded neuron from −60 mV to −80 mV. This increase also decreased membrane input resistance and suppressed
the action potentials generated by positive current pulses. The arrowheads indicate the time when the data for I–V
relationship were acquired. D, current–voltage relationship for a glucose-inhibited type of neuron demonstrates
that an increase of glucose concentration reduced the slope of the relationship; the effect reversed at −98 mV,
close to the estimated K+ equilibrium potential.
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scrambled siRNA were excited and inhibited, respectively,
in response to glucose concentrating transition from 5
to 15 mM. Thus neurons transfected with siRNA for
Kir6.2 showed no excitatory response to elevated glucose
but the incidence of glucose-inhibited neurons among
these transfected neurons was not different from that of
the non-transfected nodose ganglia neurons. In contrast,
nodose ganglia neurons transfected with scrambled siRNA
showed a frequency of glucose excitation and inhibition
similar to non-infected neurons. The demonstration that
the KATP channel modulators diazoxide and tolbutamide
mimic the effects of low and high extracellular glucose
concentration on neuron excitability, and that the
depolarizing effects of hyperglycaemia were blocked by
silencing Kir6.2 subunit expression in the nodose ganglia
neurons indicate that KATP channels play a critical role
in the glucose-excitatory response. On the other hand,
the hyperpolarizing effects of hyperglycaemia observed
in glucose-inhibited neurons are not mediated by KATP
channels.
Regulation of KATP channels by phosphatidylinositol
bisphosphate
Our Western blot analysis and immunocytochemical
data indicated that all nodose ganglia neurons
expressed the KATP channel. However, only a
fraction (∼26%) of nodose ganglia neurons were
depolarized by the KATP channel modulator tolbutamide.
This suggests that intracellular messengers other
than ATP may be involved in the glucose-induced
modulation of KATP channels. Hilgeman & Ball (1996)
demonstrated that the application of phosphatidylinositol
bisphosphate (PIP2) to inside-out patches of
cardiomyocytes modulated KATP channel sensitivity
to ATP. It has been shown that PIP kinases are required
for PIP2 synthesis (Doughman et al. 2003). Our studies
showed that intracellular treatment of nodose neurons
with the PIP kinase inhibitor wortmannin (50 nM,
Vanhaesebroeck et al. 2001) hyperpolarized 7/17 (41%)
recorded neurons by 17 mV (mean 17 ± 4 mV) and
the hyperpolarization was associated with a decrease
Figure 4. Kir6.2 and SUR1 protein expression in the rat nodose ganglia
A, representative immunoblot from the nodose ganglia shows Kir6.2 and SUR1 protein expression; actin used
as loading control. B, immunohistochemistry studies to identify neurons containing the inwardly rectifying K+
channels in nodose ganglion cross-section. Calibration bar, 100 μm. C, representative immunofluorescence
staining for SUR1 (left), the inwardly rectifying K+ channel Kir6.2 (middle), and overlay (right) in a nodose ganglion
neuron. Calibration bar, 20 μm.
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in membrane input resistance from 353 (mean
353 ± 34 M) to 120 M (mean 120 ± 31 M). The
effect of wortmannin reversed at −91 ± 4 mV. Of the
remaining 10 recorded neurons, two were depolarized
and eight were unaffected by wortmannin treatment. In
response to extracellular superfusion of tolbutamide, 5/7
(72%) wortmannin-treated neurons were depolarized
and showed an increased membrane input resistance
(n = 7, Fig. 7A), indicating that this effect is mediated
by the closure of K+ channels. Moreover, intracellular
dialysis with wortmannin, which depleted intracellular
PIP2, increased the excitability of neurons to glucose. Four
of five wortmannin-treated neurons (80%) responded
to elevation of extracellular glucose from 5 to 15 mM
(Fig. 7B). These data indicate that PIP2 can determine
the excitability of the nodose ganglia neurons to
extracellular glucose by modulating the activity of KATP
channels.
Effects of glucose metabolism inhibitor 2-DG on
nodose ganglia neuron membrane properties
In 3/15 recorded nodose ganglia neurons, extracellular
application of 15 mM 2-DG, a non-metabolizable glucose
analogue, depolarized the membrane potential to a level
sufficient to evoke action potentials (Fig. 8A). In 4/15
neurons, 2-DG generated membrane hyperpolarization
(Fig. 8B). These observations indicate that inhibition
of glucose metabolism with 2-DG can either excite or
inhibit nodose ganglia neurons, suggesting that glucose
metabolism is involved in both types of glucose-evoked
Figure 5. Effects of KATP channel modulators on membrane properties of nodose ganglia neurons
A, continuous membrane potential recordings depict the typical response to extracellular superfusion of
tolbutamide (200 μM) in an isolated nodose ganglion neuron. B, tolbutamide (200 μM) shifted the I–V relationship
in a depolarized direction, and changed the slope of the relationship, indicating increased input resistance. I–V
relationships crossed at −90 mV. The I–V relationship was recorded in the presence of 2 mM extracellular glucose.
C, continuous membrane potential recording demonstrating that tolbutamide (200 μM) did not attenuate the
duration or the amplitude of the hyperpolarization current generated by ‘high’ glucose concentration, indicating
that KATP channels do not modulate the excitability of glucose-inhibited neurons. D, extracellular application of
diazoxide (100 μM), a KATP channel activator, generated a shift of the I–V relationship, hyperpolarizing duration and
decreasing membrane input resistance. The I–V relationship was recorded in the presence of 15 mM extracellular
glucose.
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Figure 6. Lentivirus-based transfection of shRNA for Kir6.2 suppresses endogenous protein and mRNA
expression
A, Western blot demonstrating a significant reduction of Kir6.2 protein 96 h after the primary nodose ganglion
neuron cultures were transfected with lenti-Kir6.2 shRNA. Actin was used as a loading control. B, photomicrograph
of nodose ganglion neuron transfected with lenti-shKir6.2 and cultured for 96 h displaying intense EGFP signal
(arrow). C, faint immunostain signal for anti-Kir6.2 antibody in the same neuron shown in B (arrow). D, photo-
micrograph of nodose ganglion neuron transfected with scrambled siRNA and cultured for 96 h displaying
intense EGFP signal (arrow). E, immunostain signal for anti-Kir6.2 antibody in the same neuron shown in
D (arrow).
Figure 7. Effects of wortmannin on the membrane properties of nodose ganglia neurons
A, continuous membrane potential recording from wortmannin (50 nM)-treated neuron in response to extracellular
superfusion of tolbutamide (200 μM). Tolbutamide depolarized the recoded neuron from −75 to −46 mV, an
effect associated with the increase in membrane input resistance from 110 to 596 M. The effect of tolbutamide
was reversible. B, wortmannin treatment enhanced the neuronal sensitivity to glucose. Current-clamp recordings
demonstrate that an increase in extracellular glucose concentration depolarized the recorded neuron from −85 to
−67 mV and increased the membrane input resistance from 98 to 250 M. In addition, the glucose concentration
transition decreased the threshold for action potential triggering from −560 to 150 pA. The I–V relationship
demonstrates that the glucose effect reversed at ∼ −110 mV, which is close to the theoretical K+ ion reversal
potential in the conditions recorded.
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response. Alternatively, glucose uptake may also be
involved in these actions of glucose.
Discussion
Our studies demonstrate the existence of a
subpopulation of glucose-excited and glucose-inhibited
neurons in the rat nodose ganglia. Differential distribution
of these two responses occurred among gastric- and
portal vein-projecting nodose ganglia neurons. In
glucose-excited neurons, glucose metabolism leads
to closure of KATP channels, triggering membrane
depolarization, whereas in glucose-inhibited neurons, the
inhibitory effects of an elevated glucose concentration
is mediated by an ATP-independent K+ channel. Our
studies also showed that PIP2 is capable of regulating the
sensitivity of KATP channels to ATP, thus determining the
excitability of glucose-excited neurons to extracellular
glucose. This provides a possible mechanism for control
of neuronal excitability through signal transduction
pathways.
Glucose sensing to date has been considered the domain
of the CNS. First identified in the hypothalamus (Mayer,
1953), glucose-sensing neurons are likely to be involved
in the control of neuroendocrine function, nutrient
metabolism and energy metabolism (Levin et al. 2004).
The physiological significance of reports that acute hyper-
glycaemia affects a subpopulation of neurons in the NTS
and DMV (Mizuno & Oomura, 1984; Kobashi & Adachi,
1994; Ferreira et al. 2001; Balfour et al. 2006) has remained
unclear because the studies did not show that NTS or DMV
neurons are the true primary sensors of peripheral glucose.
Animal studies clearly indicate that vagovagal pathways
play an important role in the regulation of gastric motility
and eating behaviour in response to acute changes in peri-
pheral blood glucose levels (Schmitt 1973; Vanderweele
et al. 1974; Grabauskas et al. 2008a; Zhou et al. 2008).
The site of glucose sensing appears to be vagal afferent
fibres projecting to the stomach (Zhou et al. 2008)
and the portal vein (Schmitt 1973; Vanderweele et al.
1974; Grabauskas et al. 2008a). Wan & Browning (2008)
reported that changes in blood glucose levels caused a post-
synaptic response in 79% of NTS neurons, implying that
glucose modulates synaptic transmission from the central
terminals of vagal afferent fibres. Our demonstration of
the existence of a subpopulation of glucose-excited and
glucose-inhibited neurons in the nodose ganglia supports
this implication.
Niijima (1982, 1983, 1984, 1988) reported that there
were glucose sensitive afferent nerve fibres in the hepatic
branch of the vagus nerve in the guinea pig whose
firing was inhibited by elevated blood glucose levels. His
methods differed from ours in both experimental design
and the species of animal used. He observed decreased
frequency in electrical firing of the distal cut end of the
vagus nerve in response to administration of glucose into
the portal vein. His recording was made from bundles of
fibres rather than single fibres, and hence the net result
represents a summation of responses to different fibres,
some of which may be excitatory while others may be
inhibitory. Our data show that the majority of the glucose
sensing nodose ganglia neurons projecting to the portal
vein were inhibited by elevated ambient glucose.
Mei et al. (1978) reported that perfusion of the upper
small intestine stimulated some vagal neurons in the
cat. The stimulating effect of intestinal glucose may be
mediated by direct action of glucose on vagal afferent
fibres or by serotonin released in response to glucose in
the lumen (Zhu et al. 2001). These data differ from ours
in species and the methods of recording. Mei et al. used
sharp electrodes to record vagal discharges and did not
address the effects of glucose on membrane potential and
input resistance. These are important properties for the
characterization of glucose inhibitory actions.
Chambert et al. (1993) and Adachi et al. (1984)
measured the activities of NTS neurons in response to
infusion of glucose into the rat portal vein. Both excitatory
and inhibitory responses were reported (Chambert et al.
(1993), Table 2). In both the abstract and the discussion
the authors stated that only glucose inhibitory responses
were observed. It is important to note that in contrast to
our studies, the glucose concentration used was 300 mM,
significantly higher than our 5–15 mM. Furthermore, NTS
neurons often serve as relay neurons which integrate
Figure 8. Continuous membrane potential recording
demonstrates that extracellular superfusion of 2-deoxyglucose
(2-DG), a glucose metabolism inhibitor, generated either
depolarization or hyperpolarization of neuronal membrane
potential
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signals coming from other sensing neurons, including
the nodose ganglia. This group also reported that NTS
neurons which decreased firing during portal infusion of
glucose were also glucose sensitive to topical application
of glucose (Adachi et al. 1984). Hence it is plausible
that the observed effects were due to systemic glucose
acting directly on NTS neurons or were merely due to
relayed signals from the nodose ganglia. Explanation of
these results is complex and requires further studies for
clarification.
Gastric-projecting neurons from the nodose ganglia
have a significantly higher incidence of an excitatory
response to glucose compared with portal vein-projecting
neurons. When stimulated by hyperglycaemia, this group
of glucose-excited neurons may activate vagal efferent
cholinergic pathways synapsing with intragastric nitric
oxide-containing neurons to mediate gastric relaxation
(Zhou et al. 2008). The findings of Zhou et al (2008) who
showed that hyperglycaemia stimulates vagal afferents,
which inhibits gastric motility, should be contrasted with
that reported by Shi et al (2003) who showed that hyper-
glycaemia failed to inhibit spontaneous or bethanechol
induced contractions in rats, as measured by a strain gauge
force transducer sutured to the antrum. On the other hand,
intravenous infusion of glucose inhibited antral contra-
ctions stimulated by insulin-induced hypoglycaemia. This
inhibitory action of glucose was not affected by sectioning
the hepatic branch of the vagus nerve, nor by capsaicin
treatment. This led to the suggestion that afferent pathways
are not involved in glucose sensing. These differences in
findings may be related to the methods used to stimulate
and record gastric pressure. Shi et al. (2003) measured
antral motility using a strain gauge transducer sutured to
the antrum, whereas Zhou et al. (2008) recorded intra-
gastric presence with the use of a water-filled balloon
and hence the stomach was partially distended and more
sensitive for detecting gastric relaxation. Furthermore, it is
not surprising that the inhibitory effect of glucose on antral
contraction induced by hypoglycaemia was not sensitive to
capsaicin treatment. Since insulin-induced hypoglycaemia
acts centrally to stimulate gastric contractions, we would
not expect this action to be affected by glucose acting on
the vagal afferent fibres.
Animal studies indicate that changes in glucose
concentrations in the portal vein also significantly
affect eating behaviour (Schmitt 1973; Vanderweele et al.
1974; Grabauskas et al. 2008a). Our demonstration that
portal vein-projecting neurons have a significantly higher
incidence of inhibitory response to glucose may explain
the observations of Russek (1963) and others (Tordoff
& Friedman, 1986; Tordoff et al. 1989) who showed that
intraportal infusion of glucose suppressed food intake
in experimental animals. In general it is believed that
mediators that increase afferent firings in the vagus nerve
result in a reduction of food intake, while a decrease in
vagal activity results in increased food intake. This concept,
however, is based on older studies where recordings were
made from bundles of afferent fibres (Niijima, 1982,
1983, 1984, 1988), which may contain fibres that may
be excited or inhibited by glucose. Furthermore, whether
stimulation of vagal afferents results in increased or
decreased feeding may depend on their distal projections
in the hypothalamus where some of the hypothalamic
neurons may contain anorexigenic peptides while others
process orexigenic peptides.
Regulation of the KATP channel by ATP derived
from glucose metabolism has been proposed to
be responsible for glucose-excitatory action in CNS
glucose-sensing neurons (Trapp et al. 1997). Miki et al.
(2001) demonstrated that mice with the Kir6.2 gene
deleted lack glucose-excited neurons in the hypothalamus.
In the present study, we showed that nodose ganglia
neurons express KATP channel-forming subunits Kir6.2
and SUR1. Further, we showed that transfection with
Kir6.2 shRNA abolished the response of nodose ganglia
neurons to elevated glucose concentration or extracellular
application of tolbutamide. These observations support
the notion that KATP channels play a critical role in the
glucose excitatory response in the rat nodose ganglia.
Although most neurons in the rat nodose ganglia
contain KATP channels, only 26% exhibit glucose excitatory
properties. This finding is similar to observations in
the hypothalamus (Karschin et al. 1997; Dunn-Meynell
et al. 1998) which suggest that other elements may
contribute to regulating the sensitivity of the KATP
channel to glucose stimulation. As shown in our 2-DG
experiments, inhibition of glucose metabolism can either
inhibit or excite nodose ganglia neurons. In pancreatic
β cells, glucokinase regulates glycolytic flux and intra-
cellular ATP production (Heimberg et al. 1996) and is
a primary regulator of ATP production, KATP channel
activity, and insulin secretion (Routh et al. 1997). A
similar mechanism may be applicable to glucose-excited
neurons in the nodose ganglia. Glycolysis of glucose
mediated by glucokinase raises the ATP : ADP ratio and
inactivates the KATP channel. The increased ATP : ADP
ratio leads to membrane depolarization, calcium influx,
and increased firing rates in glucose-excited neurons.
Hence, as demonstrated in the ventromedial hypothalamic
nucleus, ATP production may be a key regulatory step in
the glucose excitatory response (Routh et al. 1997).
A number of regulatory molecules may modulate the
gating of KATP channels. Among these, PIP2 has been
shown to reduce the sensitivity of KATP channels to ATP
(Hilgemann & Ball, 1996; Baukrowitz et al. 1998). Our
data indicate that depletion of intracellular PIP2 using
wortmannin increases the fraction of glucose-excited
neurons from 26% to 80%, suggesting that intracellular
PIP2 levels affect the glucose-sensing ability of nodose
ganglia neurons. The specificity of wortmannin may
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depend on the concentration used. We employed a
concentration of 50 nM, which has been shown to be
rather specific in inhibiting PIP kinase (Vanhaesebroeck
et al. 2001). Although wortmannin may also inhibit
myosin-light kinase, phosphatidylinositol 4-kinase, PKA,
PKC and PKG, these inhibitory actions are not observed in
concentrations up to 1 μM (Nakanishi et al. 1995; Ui et al.
1995).
In contrast to the glucose-excited neurons in the
nodose ganglia, KATP channels are not involved in
mediating the hyperpolarization response to high glucose
levels in glucose-inhibited neurons. The mechanism
of glucose-induced neuronal inhibition is less under-
stood. Several mechanisms have been proposed, including
activation of an electronic Na+ pump (Oomura et al.
1974), activation of ATP sensitive Cl− channels (Song
et al. 2001; Routh, 2002) or inhibition of Na+/K+-ATPase
(Routh, 2002). Oomura et al. (1974) found that
extracellular applications of the Na+/K+-ATPase blocker
ouabain reversed the inhibitory effects of high glucose
on the firing of the lateral hypothalamus neurons.
These findings, together with the observation that
glucose inhibition was abolished by the metabolic poison
azid (Oomura et al. 1974), led these investigators to
propose that glucose stimulates the Na+/K+-ATPase pump
resulting in hyperpolarization and inhibition of the hypo-
thalamic neurons. However, there are inconsistencies in
this interpretation as ouabain inhibition of the pump
is irreversible but in Oomura’s studies, the inhibitory
action of ouabain on glucose action is reversible.
The contribution of Na+/K+-ATPase to glucose-induced
inhibition remains unresolved to this day.
Glucose-induced activation of post-synaptic Cl−
channels has also been proposed to explain the inhibitory
action of glucose on the hypothalamic neurons. Song et al.
(2001) reported that in rats ventromedial hypothalamic
(VMH) neurons, an increase in intracellular glucose
concentration induced membrane hyperpolarization and
activated a current with a reversal potential of −50 mV,
a value close to that of Cl− (−57 mV) in the solution.
Similar observations were made by others (Routh,
2002; Fioramonti et al. 2007). However the Cl− theory
has been rejected by recent studies using the VMH
neurons (Burdakov et al. 2006; Williams & Buradakov,
2009). These studies showed that biophysical elimination
of all inhibitory Cl− currents did not affect glucose
induced inhibition of the VMH neurons. The membrane
current–voltage relationship demonstrated that glucose
activates a current selective for K+ ions. Therefore it
appears that at least in the hypothalamic neurons, the
final effector mediating glucose induced inhibition is
K+ currents (Burdakov & Lesage, 2009). In our study,
the hyperpolarization response of the nodose ganglia
neurons to high glucose levels appears to be mediated
by the opening of a K+ channel that is insensitive to
ATP. Although the exact nature of this current is unclear,
our preliminary studies indicate that it is abolished by
the Ca2+ chelator BAPTA but not attenuated by the
specific Ca2+-activated K+ channel antagonists ibertoxin
and apamin (Grabauskas et al. 2008b). Identification of
this current requires further investigation.
In summary, we have demonstrated the existence of
subpopulations of glucose-excited and glucose-inhibited
neurons in the rat nodose ganglia. In glucose-excited
neurons, metabolism of glucose leads to increased ATP
production and closure of the KATP channel, triggering
a membrane depolarization. The inhibitory effect of
elevated glucose in glucose-inhibited neurons is mediated
by an ATP-independent K+ channel. Understanding
peripheral glucose sensing as it relates to digestive
function and feeding behaviour will provide information
critical to the medical management of obesity and
the treatment of diabetic patients with gastrointestinal
complications.
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